IGFBP2 and breast cancer: Having shown that IGFBP-2 is involved in hyperglycaemia-induced chemo-resistance and that IGFBP-2 secretion was also induced by activation of nuclear ERs, we then investigated the effect of inducing IGFBP-2 secretion in breast cancer cells by estrogen and then monitoring their response to chemotherapy.